SCHEMBL23743373

SCHEMBL23743373

CC1(C)c2cccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2-c2ccc3cc(-c4ccccc4)ccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.36
▸ ESR2 Q92731 2/20 0.36
▸ HSD17B1 P14061 4/20 0.35
▸ HSD17B2 P37059 4/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2B6 P20813 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ PDK2 Q15119 4/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24778314 0.92 ALDH1A1 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23743298 0.92 ALDH1A1 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23743271 0.92 PDK2 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23743371 0.92 PDK2 (0.34) PDK2L3MBTL1ADORA3ALOX15TSHR
SCHEMBL22038469 0.91 SMN1; SMN2 (0.35) PDK2L3MBTL1TSHRMEN1ALDH1A1
SCHEMBL23743289 0.90 MAPT (0.38) CYP1A2CYP2C9CYP2C19L3MBTL1ADORA3
SCHEMBL23743372 0.89 TSHR (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL22868968 0.89 PDK2 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23743379 0.89 AURKA (0.35) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL23743275 0.88 MAPT (0.40) L3MBTL1ADORA3ALOX15TSHRADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 ESR1 879/4885ESR2 2207/4885HSD17B1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback